Psychedelics Investing Awakn Life Sciences Bristol Clinic Receives Care Quality Commission Approval to Begin Treatments in the UK's First Medical Psychedelic Clinic
CEO Interviews Universal Ibogaine CEO Dr. Rami Batal: Well Funded to Develop an Innovative Addiction Treatment Model
Psychedelics Investing KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand Viewing
Cannabis Investing KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand Viewing
Psychedelics Investing Levitee Labs Announces Agreement with Adracare, a WELL Health Company, to Support Individuals with Addiction and Mental Health Conditions
Cannabis Investing IBN and PsychedelicNewsWire to Further Collaborate with Microdose Psychedelic Insights for Upcoming Psychedelic Capital Conference
Psychedelics Investing Levitee Labs Appoints Dr. Mohammed Mosli as Chief People Officer of Levitee Clinics and Pharmacies in Alberta, Canada
